Osaka, Japan, Paris, France and Boston, MA, USA — January 6, 2016

Takeda Pharmaceutical Company Ltd. and Enterome Bioscience SA today announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including inflammatory bowel diseases.

Download the press release (.pdf format)

EN:    FR: